Construction and screening of phage antibody libraries against epidermal growth factor receptor and soluble expression of single chain Fv

Yaoxue Xuebao

Volumn 44, Issue 6, 2009, Pages 597-602

  Sheng, Wei Jin ^a   Miao, Qing Fang ^a   Zhen, Yong Su ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Epidermal growth factor receptor; Phage antibody library; Single chain Fv; Soluble expression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; RECOMBINANT ANTIBODY; RNA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY LIBRARY; ANTIBODY SCREENING; ANTIGEN BINDING; ARTICLE; BACTERIAL CELL; CARCINOMA CELL; CELL MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHAGEMID; SEQUENCE HOMOLOGY; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MICE; MICE, INBRED BALB C; PEPTIDE LIBRARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CHAIN ANTIBODIES;

EID: 68549133356     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fortunato C, Giampaolo T. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor [J]. Clin Cancer Res, 2001,7:2958-2970. (Pubitemid 32963812)
2. Zhen YS. Antibody-based drugs and target therapy of tumor [J]. J Med Res, 2007,36:1-2.
3. Ellis LM, Hoff PM. Targeting the epidermal growth factor receptor: an important incremental step in the battle against colorectal cancer [J]. J Clin Oncol, 2004,22:1177-1179. (Pubitemid 41079828)
4. Shen BF. Antibodies for tumor therapy and their modification strategy [J]. Chin J Cancer Biother, 2007,14:10-14.
5. Mc Caggerty J, Griffiths AD, Winter G, et al. Phage antibodies: filamentous phage displaying antibody variable domains [J]. Nature, 1990,348:552-554. (Pubitemid 120015109)
6. Demarest SJ, Glaser SM. Antibody therapeutics, antibody engineering, and the merits of protein stability [J]. Curr Opin Drug Discov Devel, 2008,11:675-687.
7. Wrann MM, Fox CF. Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line [J]. J Biol Chem, 1979,254:8083-8086.
8. He Z, Wang SP, Xiao XQ. Construction, screening and application of single-chain Fv antibody library against immature egg of Schistosoma japonicum [J]. Prog Biochem Biophy, 2008,35:921-928.
9. Zhen YS. Microbial biopharmaceuticals and antibody-based drugs - promising for new drug discovery and development [J]. Acta Pharm Sin, 2003,38:483-484.
10. Bosslet K, Lorenz P, Sedlacek HH. Molecular and functional characterization of a fusion protein suited for tumor specific prodrug activation [J]. Br J Cancer, 1992,65:234-242.
11. Pastan I, Hassan R, FitzGerald DJ, et al. Immunotoxin treatment of cancer [J]. Annu Rev Med, 2007,58:221-237.
12. Elizabeth OS, Gustavo H, Tracy RD, et al. Antibody- cytokine fusion proteins: applications in cancer therapy [J]. Exp Opin Biol Ther, 2008, 8: 609-632. (Pubitemid 351685026)